Continual Cuffless BP Monitoring Can Classify Time-in-Target-Range Accurately
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, July 12, 2024 -- Continual cuffless blood pressure (BP) monitoring can classify time-in-target-range (TTR) accurately, according to a study published online June 26 in Frontiers in Medicine.
Naomi D.L. Fisher, M.D., from Brigham and Women's Hospital in Boston, and colleagues examined the optimal duration and frequency for reliable, practice TTR assessment in clinical settings using continual monitoring in a retrospective study analyzing 2.3 million BP readings from 5,189 individuals using a cuffless BP monitor. Over 15 consecutive days, systolic BP data were assessed and participants were classified into risk-related TTR groups; measurement frequencies and durations were compared to this reference. Two specific configurations paralleling ambulatory ("One-Day-24h") and home ("One-Week-Daytime") BP monitoring were further analyzed.
The researchers found that 63.0, 19.0, and 18.0 percent of the participants were classified as high-, intermediate-, and low-risk, respectively, based on the reference TTR. Compared with the reference TTR, "One-Day-24h" and "One-Week-Daytime" inaccurately classified 26 and 45 percent of participants, respectively. With both schedules, classification accuracy was high for participants with very low or very high reference TTR, but otherwise was poor. Only with seven days of continual 24-hour monitoring was there accuracy of ≥90 percent in TTR classification.
"Our results suggest that continual cuffless BP monitoring enables rapid and practical assessment of systolic BP TTR, an emerging metric of hypertension control," the authors write.
Several authors disclosed ties to medical device companies, including Aktiia, which manufactures the cuffless device used in the study.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-13 01:15
Read more
- Abortion Rights Measures Pass in 7 States, Fail in 3
- Arrowhead Pharmaceuticals Submits New Drug Application to U.S. FDA for Plozasiran for the Treatment of Familial Chylomicronemia Syndrome
- Fasting at Night May Aid Glucose Metabolism in Night-Shift Workers
- COVID-19 Linked to Long-Term Risk for Autoimmune, Autoinflammatory Disease
- Money, Education Helps Determine Your Odds for Dementia
- Novartis Scemblix Granted FDA Accelerated Approval in Newly Diagnosed CML
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions